Depending on the court ruling, Apple plans to remove sensors from certain watch models as part of a patent dispute resolution.

Apple is willing to remove the blood-oxygen sensor from its internet-connected watches, specifically the Series 9 and Ultra 2 models, if a court does not grant additional leeway during its pursuit to overturn a ruling that has blocked the use of this technology. The potential redesign, excluding the blood-oxygen sensor, has received approval from the U.S. Customs and Border Protection, as indicated in a court filing by Masimo, a Southern California company involved in a patent claim against Apple.

The filing did not provide details on how Apple plans to remove the blood-oxygen sensor, but analysts speculate that it could be achieved through a software update. Masimo secured a favourable ruling from the U.S. International Trade Commission in October, leading Apple to temporarily halt sales of the affected Apple Watch models. The appeals process is expected to take at least a year, prompting Apple to seek an extended stay to continue selling watches with blood-oxygen sensors, positioning them as health-monitoring devices.

Apple has not commented on the court filing, which reveals its plan to remove the sensor if the stay is not extended. In the ongoing legal dispute, Masimo and Apple present contrasting views on the technology involved. Masimo claims to be a pioneer in blood-oxygen sensors on wearables and accuses Apple of luring away its employees. Apple, in response, denies infringing on Masimo's limited availability technology, emphasizing its significant market share in the smartwatch industry.

The U.S. Court of Appeals in Washington is expected to decide on extending the stay later this month, determining whether the Series 9 and Ultra 2 can continue to be sold with the blood-oxygen sensors while the appeal is under review.

कोर्ट के फैसले पर निर्भर करेगा, एप्पल ने कुछ वॉच मॉडल्स से सेंसर हटाने की योजना बनाई है।